Search Your Queries Related To Trilegal

Harsh Maggon

Partner - Corporate

Mergers and Acquisitions (Public & Private) | Private Equity

Harsh Maggon

Contact D: +91 2240791799
T: +91 2240791000
E: harsh.maggon@trilegal.com
Mumbai

Overview

Harsh Maggon specialises in public and private M&A and private equity transactions. He has advised on some of the largest and control deals in India, including multiple takeover offers, schemes of arrangement and delisting offers.

In addition, Harsh has advised boards of directors and senior management of Indian listed companies on complex governance issues and assisted in developing strategies to deal with potential minority shareholder claims and regulatory action. He has extensive experience in advising private equity funds and foreign strategic investors on complex deals, regulatory issues and concerns that typically arise in Indian deals when negotiating with Indian promoters/sellers.

Harsh also focuses on the firm’s Healthcare and Lifesciences practice and has extensive experience in this space. He routinely advises some of the largest hospital and pharma companies including the Manipal group, Max group and J.B. Chemicals.

Education

B.S.L.LLB

Admissions

Bar Council of Maharashtra and Goa

Select representative clients/matters

  • Manipal Group
    on sale of majority stake to Temasek and sales by TPG and NIIF (for approx. USD 3.5 billion); fund raising from National Infrastructure and Investment Fund (approx. 300 million).
  • JM Baxi
    on sale by Bain and joint venture with Hapag Lloyd (approx. USD 1.5 billion).
  • Zee Group
    advising on the merger of Zee Entertainment Limited with Sony India to create a merged company valued at approx. USD 10 billion.
  • Brookfield Private Equity
    acquisition of a significant stake in the plastics films business of Jindal Polyfilms Limited (approx. USD 300 million).
  • KKR-Radiant
    on their acquisition of Max Hospitals for approx. USD 1 billion
  • Reliance Industries
    acquisition of Den Networks (approx. USD 1 billion) and Alok Industries (approx. USD 800 million)
  • Piramal
    sale of Piramal Glass to Blackstone for approx. USD 1 billion

Recognition

  • Up and Coming – Corporate/M&A, Chambers and Partners (Asia-Pacific) 2023
  • ‘Notable Practitioner’ ’ by the IFLR1000 Guide, from 2018 to 2022
  • ‘Notable Practitioner’ for Corporate & M&A, Asialaw 2022.

Publications from Harsh Maggon

Not just a change in nomenclature

Disclaimer

Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:

  • You are seeking information about Trilegal of your own accord and there has been no form of solicitation, advertisement or inducement by Trilegal or its members.
  • This website should not be construed as providing legal advice for any purpose.
  • All information, content, and materials available on this website are for general informational purposes only.
  • Any information obtained or material downloaded from this website is completely at the user’s volition, and any transmission, receipt or use of this website is not intended to, and will not, create any lawyer-client relationship.
  • Information on this website may not constitute the most up-to-date legal or other information. Trilegal is not liable for the consequences of any action taken by any person based on any material or information available on this website, or for any inaccuracy in or exclusion of any information or interpretation thereof.
  • Readers of this website or recipients of content or information available on this website should not act based on any or all such content or information, and should always seek advice of competent legal counsel licensed to practice in the appropriate jurisdiction.
  • Third party links contained on this website re-directing users to such third-party websites should neither be construed as legal reference / legal advice, nor considered as referrals to, endorsements of, or affiliations with, any such third party website operators.
  • The communication platform provided on this website should not be used for exchange of any confidential, business or politically sensitive information.
  • The contents of this website are the intellectual property of Trilegal.

We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:

  • The types of information we collect and why we collect them.
  • How we use your information to provide a personalized experience.
  • The measures we take to ensure the security of your data.
  • Your rights and choices in managing your personal information.
  • How we may share information with trusted partners for specific purpose.

For more information, please read our terms of use and our privacy policy.

Up arrow